These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8275488

  • 21. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T.
    Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572
    [Abstract] [Full Text] [Related]

  • 22. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec 15; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 23. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K.
    Cancer Res; 1993 Jan 15; 53(2):368-72. PubMed ID: 8093350
    [Abstract] [Full Text] [Related]

  • 24. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S.
    Mutat Res; 2004 Apr 14; 548(1-2):61-73. PubMed ID: 15063137
    [Abstract] [Full Text] [Related]

  • 25. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, Shen CY.
    Genes Chromosomes Cancer; 1997 Dec 14; 20(4):377-82. PubMed ID: 9408754
    [Abstract] [Full Text] [Related]

  • 26. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A, Bedard YC, Li SQ, Rohan T, Kandel R.
    Mod Pathol; 2000 Nov 14; 13(11):1173-9. PubMed ID: 11106073
    [Abstract] [Full Text] [Related]

  • 27. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2002 Jun 14; 34(2):78-90. PubMed ID: 12112314
    [Abstract] [Full Text] [Related]

  • 28. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP.
    Cancer Res; 1996 Jan 01; 56(1):197-205. PubMed ID: 8548763
    [Abstract] [Full Text] [Related]

  • 29. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM, Worthy E, Gorgoulis VG, Quezado M, Anastassiades OT.
    J Pathol; 1995 Aug 01; 176(4):361-72. PubMed ID: 7562251
    [Abstract] [Full Text] [Related]

  • 30. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T, Nomura N, Mori H, Wake N.
    Gynecol Oncol; 1996 Nov 01; 63(2):173-9. PubMed ID: 8910623
    [Abstract] [Full Text] [Related]

  • 31. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.
    Massenkeil G, Oberhuber H, Hailemariam S, Sulser T, Diener PA, Bannwart F, Schäfer R, Schwarte-Waldhoff I.
    Anticancer Res; 1994 Nov 01; 14(6B):2785-90. PubMed ID: 7872719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. p53 expression, mutation, and allelic deletion in ovarian cancer.
    McManus DT, Yap EP, Maxwell P, Russell SE, Toner PG, McGee JO.
    J Pathol; 1994 Nov 01; 174(3):159-68. PubMed ID: 7823248
    [Abstract] [Full Text] [Related]

  • 35. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K, Feichtinger H, Haun M, Weiss G, Ofner D, Weger AR, Umlauft F, Grünewald K.
    Lab Invest; 1996 Jan 01; 74(1):279-89. PubMed ID: 8569192
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K, Kallioniemi A, Kallioniemi O, Chen L, Smith HS, Pinkel D, Gray J, Waldman FM.
    Cancer Res; 1992 Jun 15; 52(12):3474-7. PubMed ID: 1350754
    [Abstract] [Full Text] [Related]

  • 39. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ.
    Cancer Res; 1993 Apr 15; 53(8):1889-94. PubMed ID: 8467510
    [Abstract] [Full Text] [Related]

  • 40. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K, Sugano K, Fukayama N, Nakashima Y, Saotome K, Yokoyama T, Yokota T, Ohkura H.
    Am J Gastroenterol; 1997 Feb 15; 92(2):307-12. PubMed ID: 9040212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.